selank mastery course
Unit 2 of 11
immunopeptide origins
how an immune peptide became a brain drug
from tuftsin to selank
tuftsin is a four-amino-acid fragment of immunoglobulin G that stimulates phagocytosis. Russian researchers extended it with Pro-Gly-Pro, and the result was a peptide that crossed into the CNS and modulated anxiety circuits. this unit traces that transformation.
selank was designed by modifying tuftsin, a naturally occurring immune peptide. understanding tuftsin is essential to understanding why selank has both anxiolytic and immunomodulatory properties.
at a glance
key numbers behind the tuftsin-to-selank story.
4 residues
tuftsin: Thr-Lys-Pro-Arg, the parent immunopeptide
7 residues
selank: tuftsin + Pro-Gly-Pro stabilizing tail
1970s
tuftsin first characterized by V. Najjar at Tufts University
IgG
tuftsin cleaved from the Fc region of immunoglobulin G
tuftsin to selank, residue by residue
hover any residue to see its role. the tuftsin tetrapeptide is preserved verbatim; selank simply extends the C-terminus with proline-glycine-proline.
peptide derivation chain
tuftsin
- 1Thr
- 2Lys
- 3Pro
- 4Arg
selank
- 1Thr
- 2Lys
- 3Pro
- 4Arg
- 5Pro
- 6Gly
- 7Pro
tuftsin core (Thr-Lys-Pro-Arg)
Pro-Gly-Pro extension
interactive explorer
explore the key concepts for this unit.
immunopeptide origins explorer
key terms
definitions you will encounter throughout this unit.
T
a four-amino-acid peptide (Thr-Lys-Pro-Arg) naturally produced by enzymatic cleavage of immunoglobulin G (an antibody protein). it stimulates phagocytosis -- the process where immune cells engulf and destroy pathogens. named after Tufts University where it was discovered.
I
the most abundant antibody in human blood. IgG molecules have a Y-shape with an Fc region (the tail) that carries the tuftsin sequence. enzymes in the spleen cleave tuftsin from this Fc region during normal immune function.
P
the process by which immune cells (like macrophages and neutrophils) engulf and digest foreign particles, bacteria, or dead cells. tuftsin enhances this process, which is why deficiencies in tuftsin correlate with increased infection risk.
P
a three-amino-acid sequence (proline-glycine-proline) added to tuftsin's C-terminus to create selank. this tail resists enzymatic degradation, extending the peptide's half-life from minutes to hours, and appears to unlock CNS (central nervous system) activity not present in tuftsin alone.
R
a peptide that modulates (adjusts up or down) biological processes rather than simply blocking or activating a single receptor. selank is classified as a regulatory peptide because it influences multiple systems -- anxiety circuits, immune function, and gene expression -- through modulatory rather than on/off mechanisms.
I
part of the Russian Academy of Sciences in Moscow. the laboratory led by Nikolai Myasoedov where selank was designed in the 1990s. the same institute developed semax, another regulatory peptide derived from ACTH(4-10), using similar design principles.
from immune peptide to CNS drug
the key milestones in selank's development from tuftsin.
1970s
tuftsin discovery -- V. Najjar at Tufts University identifies a tetrapeptide from IgG that stimulates phagocytosis. named "tuftsin" after the university.
1980s-90s
Russian peptide program -- the Institute of Molecular Genetics explores tuftsin analogs. Myasoedov's team systematically modifies the C-terminus to improve metabolic stability.
1990s
selank synthesis -- Pro-Gly-Pro extension creates a stable 7-residue peptide. early animal studies reveal unexpected anxiolytic activity alongside immune effects.
2009
Russian approval -- selank approved as an intranasal anxiolytic for generalized anxiety disorder and neurasthenia. marketed as a nasal spray.
why the Pro-Gly-Pro tail matters -- the simple version
a plain-English walkthrough of how three amino acids changed everything.
tuftsin on its own is destroyed by enzymes (proteins that break down other proteins) in the bloodstream within minutes. your body treats it as a used signal -- it did its immune job, so it gets recycled. by attaching three extra amino acids (proline, glycine, proline) to tuftsin's tail end, Russian researchers created a peptide that enzymes have a much harder time cutting apart. the result -- selank -- survives long enough to reach the brain through intranasal delivery (spraying it into the nose), where it influences anxiety-related circuits that tuftsin alone could never access.
A
peptidases (enzymes that specifically cut peptide bonds) attack small peptides at predictable sites. tuftsin's Arg residue at position 4 is a prime target for carboxypeptidases (enzymes that clip amino acids off the end of a peptide chain). the Pro-Gly-Pro extension shields this site because proline's rigid ring structure creates a "kink" that most peptidases cannot grip. this is the same reason proline-rich sequences appear in collagen and other long-lived structural proteins -- the proline ring physically blocks the enzyme's active site from latching on.
advanced: why tuftsin alone fails as a drug
tuftsin has a plasma half-life (the time it takes for half the peptide to be broken down in the blood) of roughly 1-3 minutes. this is fine for its natural role -- the spleen releases it locally near immune cells, so it only needs to travel a short distance. but as an administered drug, most of it is destroyed before reaching target tissues. injected tuftsin shows immune effects only at high or repeated doses, and it has no measurable CNS activity because it cannot survive the trip from nose to brain.
advanced: other tuftsin analogs
selank is not the only modified tuftsin. semax (another Russian regulatory peptide) was designed using a similar strategy -- taking a natural signaling fragment (ACTH(4-10), a piece of adrenocorticotropic hormone) and adding a Pro-Gly-Pro tail. both peptides came from the same laboratory at the Institute of Molecular Genetics, and both gained new CNS properties that their parent fragments lacked. this shared design template suggests the Pro-Gly-Pro extension is a general-purpose stabilization strategy for short regulatory peptides, not a one-off trick specific to tuftsin.
where this has been studied
evidence from published research -- mostly from Russian laboratories with limited Western replication.
tuftsin biology
V. Najjar first isolated tuftsin from IgG in the 1970s at Tufts University. his group showed that patients with spleen removal (splenectomy) had reduced tuftsin levels and higher infection rates, establishing tuftsin as a genuine immune signal rather than a breakdown artifact.
peptide stability
Myasoedov and colleagues at the Institute of Molecular Genetics demonstrated that the Pro-Gly-Pro extension increased the peptide's effective half-life from minutes to a range that allowed measurable biological effects after intranasal administration. the exact half-life extension varies by tissue and species.
CNS penetration
the blood-brain barrier (a layer of tightly packed cells that prevents most molecules in the blood from entering the brain) blocks most peptides. selank bypasses this via intranasal delivery, traveling along the olfactory nerve pathways directly into brain tissue. radiolabeled studies in rodents confirmed selank reaches the hippocampus and cortex after nasal administration.
IgG biology
tuftsin sits at positions 289-292 of the IgG heavy chain, in the CH2 domain of the Fc region (the "stem" of the Y-shaped antibody). two enzymes release it: leukokininase in the spleen clips one end, and a carboxypeptidase trims the other. this two-step cleavage means tuftsin production depends on having a functioning spleen.
design principles: Russian regulatory peptides
how selank compares to other peptides designed using similar strategies.
selank
- parent fragment: tuftsin (from IgG antibody)
- extension: Pro-Gly-Pro C-terminal tail
- original function: immune (phagocytosis stimulation)
- gained function: anxiolytic + nootropic
- approved indication: generalized anxiety disorder (Russia, 2009)
semax
- parent fragment: ACTH(4-10) (from adrenocorticotropic hormone)
- extension: Pro-Gly-Pro C-terminal tail (same as selank)
- original function: stress hormone signaling
- gained function: nootropic + neuroprotective
- approved indication: cognitive disorders, stroke recovery (Russia)
traditional peptide drugs
- typically synthetic analogs of single hormones
- stabilized by D-amino acid substitution or PEGylation (adding polymer chains)
- designed for one receptor target
- Western pharma approach: patent, phase I-III, FDA approval
- examples: semaglutide (GLP-1), octreotide (somatostatin analog)
evidence ceiling: tuftsin biology is well-established in Western literature, but the specific Pro-Gly-Pro stabilization studies and selank's CNS penetration data come primarily from Russian laboratories. independent replication of the half-life extension claims and intranasal bioavailability data has not been published in Western peer-reviewed journals.